Steris | STE - Cash And Equivalent



Steris reported $279.7M in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
3M USD 3.71B 2.61B Jun/2025
Avanos Medical USD 90.3M 6.7M Jun/2025
Baxter International USD 2.29B 530M Mar/2025
Becton, Dickinson and Co. USD 735M 68M Jun/2025
Boston Scientific USD 725M 311M Mar/2025
CONMED USD 33.93M 1.55M Jun/2025
Cooper Companies USD 124.9M 8.7M Jul/2025
Dexcom USD 1.16B 254.1M Jun/2025
Ecolab USD 1.92B 758.3M Jun/2025
Edwards Lifesciences USD 3.14B 95.4M Mar/2025
Fortive USD 1.83B 940.6M Jun/2025
Getinge SEK 2.96B 720M Dec/2024
Globus Medical USD 229.45M 231.82M Jun/2025
Haemonetics USD 292.9M 13.86M Jun/2025
Hologic USD 1.74B 305.7M Jun/2025
Idexx Laboratories USD 164.59M 624K Jun/2025
Insulet USD 1.12B 107M Jun/2025
Integra LifeSciences USD 217.91M 21.19M Jun/2025
Intuitive Surgical USD 9.53B 431.3M Jun/2025
J&J USD 38.47B 32.35B Mar/2025
Masimo USD 149.6M 18.8M Jun/2025
Olympus JPY 241.22B 11.32B Jun/2025
Owens Minor USD 59.44M 10.05M Mar/2025
ResMed USD 1.21B 276.74M Jun/2025
Steris USD 279.7M 108M Jun/2025
Stryker USD 2.38B 55M Jun/2025
Tandem Diabetes Care USD 64.11M 10.54M Jun/2025
Teleflex USD 253.7M 30.42M Jun/2025
Thermo Fisher Scientific USD 4.58B 442M Jun/2025
Zimmer Biomet Holdings USD 556.9M 827.6M Jun/2025